Effect of Bivalirudin on Aortic Valve Intervention Outcomes 2/3 (BRAVO 2/3)

Trial Profile

Effect of Bivalirudin on Aortic Valve Intervention Outcomes 2/3 (BRAVO 2/3)

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Apr 2017

At a glance

  • Drugs Bivalirudin (Primary) ; Heparin
  • Indications Thrombosis
  • Focus Adverse reactions; Registrational
  • Acronyms BRAVO 2/3
  • Sponsors The Medicines Company
  • Most Recent Events

    • 13 May 2016 Results of MRI substudy (n = 60) published in the Journal of the American College of Cardiology.
    • 08 Oct 2015 Status changed from active, no longer recruiting to completed, as per an article published in the Journal of the American College of Cardiology
    • 08 Oct 2015 Primary endpoint has not been met. (Major Bleeding), as per an article published in the Journal of the American College of Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top